Is Technology Remaking Therapy: The Screen and the Self: Telepsychiatry, AI Therapy, and the Defense Against Intimacy
Clinical Snapshot
PICO Framework
| P — Population | Patients receiving psychotherapy via technology-mediated platforms, including telepsychiatry and AI-driven therapeutic agents (Therabots) |
| I — Intervention | Technology-mediated psychotherapy — specifically telepsychiatry (video/remote delivery) and AI-driven therapeutic agents (Therabots) |
| C — Comparator | Traditional in-person psychotherapy with human therapists; implicit comparison between telepsychiatry and AI-mediated therapy |
| O — Outcomes | Therapeutic alliance quality, relational dynamics, psychological vulnerability, authenticity of the therapeutic encounter, and potential for transformative psychotherapy |
Bottom Line
This paper offers a psychoanalytically informed theoretical argument distinguishing telepsychiatry from AI-mediated therapy in terms of their impact on the therapeutic encounter. The authors contend that telepsychiatry represents a structural adaptation that preserves the essential relational and transformative elements of psychotherapy, while AI therapy risks becoming a structural collusion with patients' defenses against the vulnerability necessary for genuine therapeutic change. The argument is intellectually coherent and clinically provocative, but it is important to recognise this as expert opinion rather than evidence synthesis. No primary data are presented, no systematic review methodology is employed, and the psychoanalytic framework — while valuable — does not represent the full spectrum of evidence-based psychotherapy. The paper's most clinically useful contribution is the heuristic it offers: when evaluating digital mental health tools, clinicians should ask not merely whether outcomes are equivalent, but whether the structural form of the intervention enables or forecloses the relational conditions that make therapy transformative. For Australian practitioners, this is particularly relevant when recommending AI mental health apps to patients with complex presentations, where the absence of genuine human relational engagement may be clinically consequential rather than merely a technical limitation.
Key Findings
Effect Size: Not applicable — no quantitative data reported; this is a theoretical/narrative review
Primary Outcome: Theoretical argument that telepsychiatry preserves the essential nature of the therapeutic encounter (structural change only), whereas AI-mediated therapy (Therabots) risks colluding with patients' maladaptive psychological defenses against vulnerability and authentic intimacy, thereby fundamentally altering — and potentially undermining — the transformative potential of psychotherapy
Nnt Or Sensitivity: Not applicable — no empirical outcome measures reported; the paper's 'findings' are conceptual distinctions rather than measured treatment effects
Clinical Application
The paper's conceptual framework is immediately applicable as a clinical heuristic for practitioners evaluating digital mental health tools. The distinction between telepsychiatry (acceptable structural adaptation) and AI therapy (potential therapeutic compromise) provides a decision-support framework. However, operationalising the concept of 'defense against intimacy' in routine clinical assessment requires psychodynamic training and is not readily translatable into standardised clinical protocols or outcome measures. In Australia, telepsychiatry has been substantially expanded under Medicare Benefits Schedule (MBS) telehealth items introduced during the COVID-19 pandemic and subsequently retained, reflecting policy recognition of its equivalence to in-person care for many presentations. The RACGP and the Royal Australian and New Zealand College of Psychiatrists (RANZCP) have published telehealth guidelines broadly consistent with the paper's position that telepsychiatry does not fundamentally compromise care. AI-driven therapeutic tools (Therabots) are not currently TGA-regulated as therapeutic goods in most configurations, creating a regulatory gap that the paper's concerns about patient safety implicitly highlight. The paper's caution about AI therapy is relevant to Australian clinicians considering recommending commercial AI mental health apps (e.g., Wysa, Woebot) to patients, particularly those with complex trauma, personality disorders, or presentations requiring deep relational work. The Better Access initiative and headspace digital programs represent the Australian policy context within which these questions are being actively debated. Adult patients receiving or being considered for technology-mediated psychotherapy, including telepsychiatry platforms and AI-driven therapeutic applications; clinicians and health systems making decisions about digital mental health service delivery
Abstract
PURPOSE OF REVIEW: This paper examines several methods of technology that have challenged traditional expectations of the meaning of psychotherapy, from the widespread adoption of telepsychiatry to the subsequent emergence of AI-driven therapeutic agents (Therabots). RECENT FINDINGS: Widespread usage of new technology that impacts the therapeutic process has outpaced an analysis of how that technology might affect the meaning and effectiveness of that process. Lawsuits assume such technology causes harm, while limited data and the literature has been more mixed. From Frankenstein to CRISPR, new technology always has its cheerleaders and its detractors. The more the technology seems to impact a topic especially connected to our humanity, the deeper the convictions will be on both sides. Certainly, when it comes to psychotherapy, the introduction of new technologies such as telepsychiatry to Therabots has provoked discussion. We argue that while new technologies offer practical advantages, they risk functioning as structural defenses against the vulnerability and authentic intimacy essential to transformative psychotherapy. Through analysis of the therapeutic alliance, relational dynamics, and the psychology of vulnerability, this paper contends that the structural form of telepsychiatry does not alter the inherent nature of the therapeutic experience, whereas AI-mediated therapy may collude with maladaptive defenses, fundamentally altering the nature of the therapeutic encounter.
References
- 1.Zuberi, N., & Ringel, C. B. (2026). Is technology remaking therapy: The screen and the self: Telepsychiatry, AI therapy, and the defense against intimacy. Current Psychiatry Reports. https://doi.org/10.2196/69294
Related Research
Journal of psychiatric research
Systematic review of machine learning and deep learning models for EEG-based detection of depression.
2 Aug 2026
Sleep medicine reviews
Artificial intelligence in sleep medicine I: Diagnosis, treatment, care, and research
2 Aug 2026
International journal of yoga therapy
Randomized Controlled Trial on the Effect of Yoga on Anxiety Severity, Quality of Life, and Biomarkers in Individuals with Anxiety Disorder
31 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service